Both in Biotechnology
Protara Therapeutics vs enGene Therapeutics
Over the past year TARA returned −49.4% and ENGN returned −73.7%; their daily moves had a correlation of 0.19.
TARA −49.4% ENGN −73.7%Growth of $1, one year, split-adjusted
| Metric | TARA | ENGN |
|---|---|---|
| Price | $2.35 | $1.72 |
| Market cap | $138.9M | $115.3M |
| Today | −2.49% | +6.17% |
| 1 month | −8.0% | −4.4% |
| 6 months | −58.5% | −80.6% |
| Year to date | −55.9% | −81.0% |
| 1 year | −54.1% | −75.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $142.5M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 48.4% | 58.2% |
| Short % of float | 11.5% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).